SUPIROCIN mupirocin (as calcium) 2% w/w cream tube

Pajjiż: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

mupirocin calcium, Quantity: 21.5 mg/g

Disponibbli minn:

Glenmark Pharmaceuticals Australia Pty Ltd

Għamla farmaċewtika:

Cream

Kompożizzjoni:

Excipient Ingredients: cetomacrogol 1000; phenoxyethanol; purified water; liquid paraffin; glyceryl monostearate 40-55 per cent; benzyl alcohol; xanthan gum

Rotta amministrattiva:

Topical

Unitajiet fil-pakkett:

15 G

Tip ta 'preskrizzjoni:

(S4) Prescription Only Medicine

Indikazzjonijiet terapewtiċi:

SUPIROCIN (mupirocin) cream is indicated for the topical treatment of secondarily infected traumatic skin lesions such as small lacerations, sutured wounds or abrasions.

Sommarju tal-prodott:

Visual Identification: White soft homogeneous cream; Container Type: Tube; Container Material: Al; Container Life Time: 18 Months; Container Temperature: Store below 25 degrees Celsius

L-istatus ta 'awtorizzazzjoni:

Registered

Data ta 'l-awtorizzazzjoni:

2023-05-24

Fuljett ta 'informazzjoni

SUPIROCIN CREAM
1
SUPIROCIN CREAM
Consumer Medicine Information (CMI) summary
The full CMI on the next page has more details. If you are worried
about using this medicine, speak to your doctor or pharmacist.
1. Why am I using SUPIROCIN cream?
SUPIROCIN cream contains the active ingredient mupirocin calcium.
SUPIROCIN cream is used for the topical treatment of
secondarily infected traumatic skin lesions such as small lacerations,
sutured wounds or abrasions.
For more information, see Section 1. Why am I using SUPIROCIN cream?
in the full CMI.
2. What should I know before I use SUPIROCIN cream?
Do not use if you have ever had an allergic reaction to mupirocin or
mupirocin calcium or any of the ingredients listed at the
end of the CMI.
Talk to your doctor if you have any other medical conditions, take any
other medicines, or are pregnant or plan to become
pregnant or are breastfeeding.
For more information, see Section 2. What should I know before I use
SUPIROCIN cream? in the full CMI.
3. What if I am taking other medicines?
Some medicines may interfere with SUPIROCIN cream and affect how it
works.
A list of these medicines is in Section 3. What if I am taking other
medicines? in the full CMI.
4. How do I use SUPIROCIN cream?
•
A small amount of SUPIROCIN cream should be applied to the affected
area three times daily.
More instructions can be found in Section 4. How do I use SUPIROCIN
cream? in the full CMI.
5. What should I know while using SUPIROCIN cream?
Things you
should do
• Remind any doctor, dentist or pharmacist you visit that you are
using SUPIROCIN.
• If SUPIROCIN cream is accidentally applied to the eyes, wash the
eyes thoroughly with water.
• If you develop an allergic reaction, wipe off the cream, stop
using SUPIROCIN cream and tell your
doctor.
Things you
should not do
• Do not stop using this medicine suddenly.
• SUPIROCIN cream should not be used to in or near the eyes,
nostrils or mouth.
• SUPIROCIN cream should not be used to treat areas of skin near
tubes inserted into your body fo

Karatteristiċi tal-prodott

AUSTRALIAN PRODUCT INFORMATION - SUPIROCIN (mupirocin
calcium) cream
1 NAME OF THE MEDICINE
Mupirocin calcium.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
SUPIROCIN cream contains 20 mg (2% w/w) of mupirocin per gram
equivalent to 21.5 mg
(2.15% w/w) of mupirocin calcium in an oil and water based emulsion.
For the full list of excipients, see Section 6.1 LIST OF EXCIPIENTS.
3 PHARMACEUTICAL FORM
Cream
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
SUPIROCIN (mupirocin) cream is indicated for the topical treatment of
secondarily infected
traumatic skin lesions such as small lacerations, sutured wounds or
abrasions.
4.2 DOSE AND METHOD OF ADMINISTRATION
For Dermatologic Use.
A small amount of SUPIROCIN should be applied to the affected area
three times daily. The
area treated may be covered with a gauze dressing if desired. Usually
treatment should not
continue for more than 10 days.
4.3 CONTRAINDICATIONS
SUPIROCIN cream is contraindicated in patients who have demonstrated
hypersensitivity to
mupirocin calcium or any components of the formulations.
4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE
If a reaction suggesting sensitivity or chemical irritation should
occur with the use of
SUPIROCIN, treatment should be discontinued, the product should be
wiped off and
appropriate alternative therapy for the infection instituted.
SUPIROCIN is not suitable for ophthalmic use, intranasal use or
application to other
mucosal surfaces.
Avoid contact with eyes. If contaminated, the eyes should be
thoroughly irrigated with water
until the residues have been removed.
SUPIROCIN is not suitable for application to the site of cannulation
or for use in conjunction
with cannulae.
As with other antibacterial products, prolonged use may result in
overgrowth of
nonsusceptible organisms, including fungi. Appropriate measures should
be taken if this
occurs.
Pseudomembranous colitis has been reported with the use of antibiotics
and may range in
severity from mild to life-threatening. Therefore, it is important to
consider its diagnosis in
p